Bremer G L, Tiebosch A T, van der Putten H W, Schouten H J, de Haan J, Arends J W
Department of Obstetrics and Gynecology, University of Limburg, Maastricht, The Netherlands.
Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):126-31. doi: 10.1016/s0002-9378(96)70384-8.
The purpose of this study was to investigate whether the intensity of tumor angiogenesis, expressed as microvessel density, is a parameter predicting the probability of lymph node metastasis and survival in patients with cervical cancer stages IB and IIA.
In a retrospective study of 114 patients with cervical cancer stages IB and IIA, microvessel density, lymph node status, and several other prognostic parameters were correlated with disease-free survival by a multivariate analysis according to Cox proportional-hazards model.
There was a significant difference in mean microvessel density between tumors with and without pelvic lymph node metastasis (p = 0.002). Both microvessel density (vessels per square millimeter of stroma). (p = 0.05) and pelvic lymph node metastasis (p = 0.007) correlated significantly and independently with disease-free survival.
This study demonstrates that microvessel density is an independent prognostic parameter for disease-free survival in patients with cervical cancer stages Ib and IIa.
本研究旨在调查以微血管密度表示的肿瘤血管生成强度是否为预测IB期和IIA期宫颈癌患者淋巴结转移概率和生存率的一个参数。
在一项对114例IB期和IIA期宫颈癌患者的回顾性研究中,根据Cox比例风险模型,通过多变量分析将微血管密度、淋巴结状态及其他几个预后参数与无病生存期相关联。
有盆腔淋巴结转移和无盆腔淋巴结转移的肿瘤之间,平均微血管密度存在显著差异(p = 0.002)。微血管密度(每平方毫米基质中的血管数)(p = 0.05)和盆腔淋巴结转移(p = 0.007)均与无病生存期显著且独立相关。
本研究表明,微血管密度是IB期和IIA期宫颈癌患者无病生存期的一个独立预后参数。